Microglial activation in Alzheimer's disease: An (R)-[11C]PK11195 positron emission tomography study

Neurobiology of Aging

Volumn 34, Issue 1, 2013, Pages 128-136

  Schuitemaker, Alie ^a,b   Kropholler, Marc A ^b   Boellaard, Ronald ^b   van der Flier, Wiesje M ^a,b   Kloet, Reina W ^b   van der Doef, Thalia F ^b,c   Knol, Dirk L ^b   Windhorst, Albert D ^b   Luurtsema, Gert ^b   Barkhof, Frederik ^b   Jonker, Cees ^a   Lammertsma, Adriaan A ^b   Scheltens, Philip ^a   van Berckel, Bart N M ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Alzheimer's disease; Microglial activation; Mild cognitive impairment; PET

Indexed keywords

N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN MAPPING; BRAIN REGION; BRAIN SCINTISCANNING; CELL ACTIVATION; CHEMICAL BINDING; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; MICROGLIA; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; OCCIPITAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BRAIN MAPPING; CARBON RADIOISOTOPES; CLUSTER ANALYSIS; FEMALE; HUMANS; ISOQUINOLINES; MAGNETIC RESONANCE IMAGING; MALE; MICROGLIA; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 84868107574     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.04.021     Document Type: Article

References (48)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
2. Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, American Psychiatric Association, Washington, DC. 4th edition, text revision.
3. Arends Y.M., Duyckaerts C., Rozemuller J.M., Eikelenboom P., Hauw J.J. Microglia, amyloid and dementia in Alzheimer disease. A correlative study. Neurobiol. Aging 2000, 21:39-47.
4. Boellaard R., Turkheimer F., Hinz R., Schuitemaker A., Scheltens P., van Berckel B.N., Lammertsma A.A. Performance of a modified supervised cluster algorithm for extracting reference tissue input functions from (R)-[11C]PK11195 PET studies. IEEE Medical Imaging Conference Program 2008, 209. (M10-504).
5. Bouwman F.H., Verwey N.A., Klein M., Kok A., Blankenstein M.A., Sluimer J.D., Barkhof F., van der Flier W.M., Scheltens P. New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population. Dement. Geriatr. Cogn. Disord. 2010, 30:1-7.
6. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
7. Brix G., Zaers J., Adam L.E., Bellemann M.E., Ostertag H., Trojan H., Haberkorn U., Doll J., Oberdorfer F., Lorenz W.J. Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J. Nucl. Med. 1997, 38:1614-1623.
8. Cagnin A., Brooks D.J., Kennedy A.M., Gunn R.N., Myers R., Turkheimer F.E., Jones T., Banati R.B. In-vivo measurement of activated microglia in dementia. Lancet 2001, 358:461-467.
9. DiPatre P.L., Gelman B.B. Microglial cell activation in aging and Alzheimer disease: partial linkage with neurofibrillary tangle burden in the hippocampus. J. Neuropathol. Exp. Neurol. 1997, 56:143-149.
10. Dubois B., Feldman H.H., Jacova C., Cummings J.L., DeKosky S.T., Barberger-Gateau P., Delacourte A., Frisoni G., Fox N.C., Galasko D., Gauthier S., Hampel H., Jicha G.A., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Sarazin M., de Souza L.C., Stern Y., Visser P.J., Scheltens P. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 2010, 9:1118-1127.
11. 11C]PIB-PET study. Neurobiol. Dis. 2008, 32:412-419.
12. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
13. Genovese C.R., Lazar N.A., Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002, 15:870-878.
14. Gunn R.N., Lammertsma A.A., Hume S.P., Cunningham V.J. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 1997, 6:279-287.
15. 18F]-2-fluoro-2-deoxy-d-glucose and positron emission tomography: an overview of different analytical methods. Eur. J. Nucl. Med. 2000, 27:731-743.
16. Hoozemans J.J., van Haastert E.S., Veerhuis R., Arendt T., Scheper W., Eikelenboom P., Rozemuller A.J. Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease. J. Neuroinflammation 2005, 2:27.
17. Hudson H.M., Larkin R.S. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans. Med. Imaging 1994, 13:601-609.
18. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 2007, 27:1533-1539.
19. Lammertsma A.A., Hume S.P. Simplified reference tissue model for PET receptor studies. Neuroimage 1996, 4:153-158.
20. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 1996, 16:834-840.
21. Logan J., Fowler J.S., Volkow N.D., Wolf A.P., Dewey S.L., Schlyer D.J., MacGregor R.R., Hitzemann R., Bendriem B., Gatley S.J. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 1990, 10:740-747.
22. Maes F., Collignon A., Vandermeulen D., Marchal G., Suetens P. Multimodality image registration by maximization of mutual information. IEEE Trans. Med. Imaging 1997, 16:187-198.
23. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
24. Meyer-Luehmann M., Spires-Jones T.L., Prada C., Garcia-Alloza M., de Calignon A., Rozkalne A., Koenigsknecht-Talboo J., Holtzman D.M., Bacskai B.J., Hyman B.T. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 2008, 451:720-724.
25. Morris J.C., Storandt M., Miller J.P., McKeel D.W., Price J.L., Rubin E.H., Berg L. Mild cognitive impairment represents early-stage Alzheimer disease. Arch. Neurol. 2001, 58:397-405.
26. Mourik J.E., Lubberink M., van Velden F.H., Kloet R.W., van Berckel B.N., Lammertsma A.A., Boellaard R. In vivo validation of reconstruction-based resolution recovery for human brain studies. J. Cereb. Blood Flow Metab. 2010, 30:381-389.
27. Okello A., Edison P., Archer H.A., Turkheimer F.E., Kennedy J., Bullock R., Walker Z., Kennedy A., Fox N., Rossor M., Brooks D.J. Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology 2009, 72:56-62.
28. Ollinger J.M., Fessler J.A. Positron Emission Tomography, IEEE Signal Processing Magazine 14 1997, 43-55. 1st edition.
29. Papadopoulos V., Baraldi M., Guilarte T.R., Knudsen T.B., Lacapère J.J., Lindemann P., Norenberg M.D., Nutt D., Weizman A., Zhang M.R., Gavish M. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 2006, 27:402-409.
30. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med 2004, 256:183-194.
31. Petersen R.C., Parisi J.E., Dickson D.W., Johnson K.A., Knopman D.S., Boeve B.F., Jicha G.A., Ivnik R.J., Smith G.E., Tangalos E.G., Braak H., Kokmen E. Neuropathologic features of amnestic mild cognitive impairment. Arch. Neurol. 2006, 63:665-672.
32. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999, 56:303-308.
33. Price J.L., Morris J.C. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann. Neurol. 1999, 45:358-368.
34. Rozemuller J.M., Eikelenboom P., Pals S.T., Stam F.C. Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family. Neurosci. Lett. 1989, 101:288-292.
35. 11C]PK11195 binding images. J. Cereb. Blood Flow Metab. 2007, 27:1603-1615.
36. 11C]PK11195 binding images: plasma input versus reference tissue parametric methods. Neuroimage 2007, 35:1473-1479.
37. Schuitemaker A., van der Doef T.F., Boellaard R., van der Flier W.M., Yaqub M., Windhorst A.D., Barkhof F., Jonker C., Kloet R.W., Lammertsma A.A., Scheltens P., van Berckel B.N. Microglial activation in healthy aging. Neurobiol. Aging 2012, 33:1067-1072.
38. 11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Nucl. Med. Biol. 1994, 21:573-581.
39. Svarer C., Madsen K., Hasselbalch S.G., Pinborg L.H., Haugbøl S., Frøkjaer V.G., Holm S., Paulson O.B., Knudsen G.M. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 2005, 24:969-979.
40. 11C]-(R)-PK11195 brain studies. J. Nucl. Med. 2007, 48:158-167.
41. Veerhuis R., Van Breemen M.J., Hoozemans J.M., Morbin M., Ouladhadj J., Tagliavini F., Eikelenboom P. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro. Acta Neuropathol. 2003, 105:135-144.
42. Venneti S., Lopresti B.J., Wiley C.A. The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging. Prog. Neurobiol. 2006, 80:308-322.
43. West J., Fitzpatrick J.M., Wang M.Y., Dawant B.M., Maurer C.R., Kessler R.M., Maciunas R.J., Barillot C., Lemoine D., Collignon A., Maes F., Suetens P., Vandermeulen D., van den Elsen P.A., Napel S., Sumanaweera T.S., Harkness B., Hemler P.F., Hill D.L., Hawkes D.J., Studholme C., Maintz J.B., Viergever M.A., Malandain G., Woods R.P. Comparison and evaluation of retrospective intermodality brain image registration techniques. J. Comput. Assist. Tomogr. 1997, 21:554-566.
44. Wiley C.A., Lopresti B.J., Venneti S., Price J., Klunk W.E., DeKosky S.T., Mathis C.A. Carbon 11-labeled Pittsburgh compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease. Arch. Neurol. 2009, 66:60-67.
45. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat. Med. 2006, 12:1005-1015.
46. 11C]PK11195 Studies. J. Cereb. Blood Flow Metab. 2009, 29:S1-S5.
47. Yokokura M., Mori N., Yagi S., Yoshikawa E., Kikuchi M., Yoshihara Y., Wakuda T., Sugihara G., Takebayashi K., Suda S., Iwata Y., Ueki T., Tsuchiya K.J., Suzuki K., Nakamura K., Ouchi Y. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 2011, 38:343-351.
48. Yoshiyama Y., Higuchi M., Zhang B., Huang S.M., Iwata N., Saido T.C., Maeda J., Suhara T., Trojanowski J.Q., Lee V.M. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007, 53:337-351.